Early Discontinuation of Steroid Treatment in Negative FDG-PET/CT Patients With Idiopathic Retroperitoneal Fibrosis

PHASE4RecruitingINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

November 25, 2022

Primary Completion Date

November 25, 2026

Study Completion Date

November 25, 2028

Conditions
Idiopathic Retroperitoneal Fibrosis
Interventions
DRUG

Prednisone

Phase 4 Prednisone Dose : 1mg/kg/day at inclusion Route of administration : oral Duration of treatment: 9 to 21 months.

Trial Locations (15)

13005

RECRUITING

Médecine Interne - La Timone, Marseille

21000

RECRUITING

Médecine interne et immunologie clinique - Dijon, Dijon

29200

RECRUITING

Médecine interne, Brest

33604

RECRUITING

Médecine interne et maladies infectieuses - GH Sud Haut Lévêque, Bordeaux

47000

RECRUITING

Médecine Interne, Agen

59000

ACTIVE_NOT_RECRUITING

Médecine interne - Lille, Lille

75012

RECRUITING

Médecine interne - Saint Antoine, Paris

75013

RECRUITING

Médecine Interne, Vascularites et Myosites - La Pitié Salpêtrière, Paris

75014

RECRUITING

Médecine interne - Cochin, Paris

75015

RECRUITING

Médecine vasculaire - HEGP, Paris

75018

RECRUITING

Médecine Interne - Bichat, Paris

ACTIVE_NOT_RECRUITING

Néphrologie - Bichat, Paris

92100

RECRUITING

Médecine interne - Ambroise Paré, Boulogne-Billancourt

93200

ACTIVE_NOT_RECRUITING

Médecine interne - Delafontaine, Saint-Denis

94000

RECRUITING

Médecine interne - Henri-Mondor, Créteil

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER